Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials recruiting in Missouri

Fewer than 3 recruiting trials found.

All Extrapulmonary Neuroendocrine Carcinoma (EP-NEC) trials nationally

Cities in Missouri

Recruiting trials in Missouri

• A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
  NCT07488923 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
  NCT05652686 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis